For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $0.28 in the prior trading day, Biodesix Inc (NASDAQ: BDSX) closed at $8.70M, up 1356865%. In other words, the price has increased by $1356865 from its previous closing price. On the day, 1.36 million shares were traded. BDSX stock price reached its highest trading level at $0.2866 during the session, while it also had its lowest trading level at $0.2602.
Ratios:
Our goal is to gain a better understanding of BDSX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.14 and its Current Ratio is at 2.22. In the meantime, Its Debt-to-Equity ratio is 5.63 whereas as Long-Term Debt/Eq ratio is at 5.53.
On July 26, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $3.Craig Hallum initiated its Buy rating on July 26, 2024, with a $3 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 16 ’25 when SCHULER JACK W bought 4,000,000 shares for $0.27 per share. The transaction valued at 1,070,000 led to the insider holds 20,194,935 shares of the business.
SCHULER JACK W bought 723,239 shares of BDSX for $246,624 on May 19 ’25. The Director now owns 20,918,174 shares after completing the transaction at $0.34 per share. On May 12 ’25, another insider, Vazquez Chris, who serves as the Chief Accounting Officer of the company, sold 112 shares for $0.36 each. As a result, the insider received 40 and left with 18,113 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDSX now has a Market Capitalization of 38399508 and an Enterprise Value of 84661512. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.52 while its Price-to-Book (P/B) ratio in mrq is 3.47. Its current Enterprise Value per Revenue stands at 1.137 whereas that against EBITDA is -3.186.
Stock Price History:
The Beta on a monthly basis for BDSX is 0.98, which has changed by -0.84121215 over the last 52 weeks, in comparison to a change of 0.09544468 over the same period for the S&P500. Over the past 52 weeks, BDSX has reached a high of $2.04, while it has fallen to a 52-week low of $0.17. The 50-Day Moving Average of the stock is -33.98%, while the 200-Day Moving Average is calculated to be -75.11%.
Shares Statistics:
The stock has traded on average 8.70M shares per day over the past 3-months and 2457520 shares per day over the last 10 days, according to various share statistics. A total of 146.44M shares are outstanding, with a floating share count of 69.40M. Insiders hold about 52.65% of the company’s shares, while institutions hold 36.42% stake in the company. Shares short for BDSX as of 1748563200 were 5633530 with a Short Ratio of 0.65, compared to 1745971200 on 1053934. Therefore, it implies a Short% of Shares Outstanding of 5633530 and a Short% of Float of 7.57.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
